association between e-cigarette use and future combustible cigarette use: Evidence from a prospective cohort of youth and young adults, 2017-2019.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
hair (2021)
Reasons for using e-cigarettes and support for e-cigarette regulations: Findings from the 2020 ITC Malaysia Survey.
Population Clinical
Consumer Use
Reasons For Use
hairi (2022)
Nicotine delivery and users’ reactions to Juul compared with cigarettes and other e-cigarette products.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
hajek (2020)
Electronic cigarettes versus nicotine patches for smoking cessation in pregnancy: a randomized controlled trial.
Population Clinical
Cessation
Tobacco
hajek (2022)
The “gateway” effect of e-cigarettes may be explained by a genetic liability to risk-taking.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
hall (2021)
E-Cigarette Flavors, Devices, and Brand Preferences among Youths in Canada, England, and the United States: The Value and Challenges of Comparing International Survey Data.
Population Clinical
Consumer Use
Youth Use & Appeal
hallingberg (2022)
have e-cigarettes renormalised or displaced youth smoking? Results of a segmented regression analysis of repeated cross sectional survey data in England, Scotland and Wales.
Population Clinical
Consumer Use
Youth Use & Appeal
hallingberg (2020)
Perceived risks and benefits of smoking: differences among adolescents with different smoking experiences and intentions
Population Clinical
Perception Of Risk
Comparsion With Tobacco And Other Nicotine Products
halpern-Felsher (2004)
analysis of Toxic Metals in Electronic Cigarette aerosols Using a Novel Trap Design.
Nonclinical
Chemical
Analysis
halstead (2020)
Pilot Study to Detect Genes Involved in DNa Damage and Cancer in humans: Potential Biomarkers of Exposure to E-Cigarette aerosols.
Individual Clinical
Biomarkers
Biomarkers Of Exposure
hamad (2021)